Erratum: Matrix metalloproteinase-10 is upregulated by Thrombin in endothelial cells and increased in patients with enhanced thrombin generation (Arteriosclerosis, Thrombosis, and Vascular Biology (2010) 29 (2109-2116) DOI:10.1161/ATVBAHA.109.194589);Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 12, 2009, Pages 2109-2116

  Orbe, Josune ^a   Rodríguez, José A ^a   Calvayrac, Olivier ^b   Rodríguez Calvo, Ricardo ^b   Rodríguez, Cristina ^a   Roncal, Carmen ^b   De Lizarrondo, Sara Martínez ^a   Barrenetxe, Jaione ^a   Reverter, Juan C ^c   Martínez González, José ^b   Páramo, José A ^a,b,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Atherosclerosis; Endothelium; MMP 10; Thrombin; Thrombosis

Indexed keywords

BLOCKING ANTIBODY; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 1 ANTIBODY; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN 2; THROMBIN; TRAP 1 PEPTIDE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; AORTA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SITE DIRECTED MUTAGENESIS; UPREGULATION;

EID: 73849152504     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATV.0b013e3181fe3f91     Document Type: Erratum

References (36)

1. Coughlin SR, Camerer E. PARticipation in inflammation. J Clin Invest. 2003;111:25-27.
2. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131:417-430.
3. Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol. 2007;14:55-61.
4. Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 2005;3:1800-1814.
5. Hirano K. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2007; 27:27-36.
6. Martorell L, Martinez-Gonzalez J, Rodriguez C, Gentile M, Calvayrac O, Badimon L. Thrombin and protease-activated receptors (PARs) in athero-thrombosis. Thromb Haemost. 2008;99:305-315.
7. Fan Y, Zhang W, Mulholland M. Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells. J Surg Res. 2005;129: 196-201.
8. Li T, Wang H, He S. Induction of interleukin-6 release from monocytes by serine proteinases and its potential mechanisms. Scand J Immunol. 2006;64:10-16.
9. Vergnolle N, Cellars L, Mencarelli A, Rizzo G, Swaminathan S, Beck P, Steinhoff M, Andrade-Gordon P, Bunnett NW, Hollenberg MD, Wallace JL, Cirino G, Fiorucci S. A role for proteinase-activated receptor-1 in inflammatory bowel diseases. J Clin Invest. 2004;114:1444-1456.
10. Coughlin SR. Thrombin signaling and protease-activated receptors. Nature. 2000;407:258-264.
11. Duhamel-Clerin E, Orvain C, Lanza F, Cazenave JP, Klein-Soyer C. Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17:1931-1938.
12. Galis ZS, Kranzhofer R, Fenton JW II, Libby P. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:483-489.
13. Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M, Bahou WF. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J Biol Chem. 1995;270:23730- 23738.
14. Rodriguez JA, Orbe J, Paramo JA. [Metalloproteases, vascular remodeling and atherothrombotic syndromes]. Rev Esp Cardiol. 2007;60: 959-967.
15. Rodriguez JA, Orbe J, Martinez de Lizarrondo S, Calvayrac O, Rodriguez C, Martinez-Gonzalez J, Paramo JA. Metalloproteinases and athero-thrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli. Front Biosci. 2008;13:2916-2921.
16. Lijnen HR. Elements of the fibrinolytic system. Ann N Y Acad Sci. 2001;936:226-236.
17. Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodriguez JA, Diez J, Libby P, Paramo JA. C-reactive protein induces matrix metalloproteinase-1 and-10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol. 2006;47: 1369-1378.
18. Orbe J, Montero I, Rodriguez JA, Beloqui O, Roncal C, Paramo JA. Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis. J Thromb Haemost. 2007;5: 91-97.
19. Knauper V, Murphy G, Tschesche H. Activation of human neutrophil procollagenase by stromelysin 2. Eur J Biochem. 1996;235:187-191.
20. Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem. 1998;253:67-75.
21. Howell DC, Johns RH, Lasky JA, Shan B, Scotton CJ, Laurent GJ, Chambers RC. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol. 2005;166:1353-1365.
22. Orbe J, Zudaire M, Serrano R, Coma-Canella I, Martinez de Lizarrondo S, Rodriguez JA, Paramo JA. Increased thrombin generation after acute versus chronic coronary disease as assessed by thrombin generation test. Thromb Haemost. 2008;99:382-387.
23. Madlener M, Mauch C, Conca W, Brauchle M, Parks WC, Werner S. Regulation of the expression of stromelysin-2 by growth factors in kera-tinocytes: implications for normal and impaired wound healing. Biochem J. 1996;320:659-664. (Pubitemid 26417794)
24. Krampert M, Bloch W, Sasaki T, Bugnon P, Rulicke T, Wolf E, Aumailley M, Parks WC, Werner S. Activities of the matrix metallopro-teinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell. 2004;15:5242-5254.
25. Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci. 2005;118:2325-2340.
26. Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN. Histone deacetylase 7 maintains vascular integrity by repressing matrix metallo-proteinase 10. Cell. 2006;126:321-334.
27. Camerer E. Unchecked thrombin is bad news for troubled arteries. J Clin Invest. 2007;117:1486-1489.
28. Minami T, Sugiyama A, Wu SQ, Abid R, Kodama T, Aird WC. Thrombin and phenotypic modulation of the endothelium. Arterioscler Thromb Vasc Biol. 2004;24:41-53.
29. Marinissen MJ, Servitja JM, Offermanns S, Simon MI, Gutkind JS. Thrombin protease-activated receptor-1 signals through Gq-and G13-initiated MAPK cascades regulating c-Jun expression to induce cell transformation. J Biol Chem. 2003;278:46814-46825.
30. Sharony R, Pintucci G, Saunders PC, Grossi EA, Baumann FG, Galloway AC, Mignatti P. Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and-2. Am J Physiol Heart Circ Physiol. 2006;290:H1651-H1659.
31. Choi MS, Kim YE, Lee WJ, Choi JW, Park GH, Kim SD, Jeon SJ, Go HS, Shin SM, Kim WK, Shin CY, Ko KH. Activation of protease-acti-vated receptor1 mediates induction of matrix metalloproteinase-9 by thrombin in rat primary astrocytes. Brain Res Bull. 2008;76:368-375.
32. Cunningham AC, Hasty KA, Enghild JJ, Mast AE. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. Biochem J. 2002;367:451-458.
33. Levi M. Disseminated intravascular coagulation: What's new? Crit Care Clin. 2005;21:449-467. (Pubitemid 40898154)
34. Ugwu F, Lemmens G, Collen D, Lijnen HR. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3). Thromb Haemost. 1999;82:1127-1131.
35. Galis ZS, Sukhova GK, Lark MW, Libby P, Camerer E, Coughlin SR. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
36. Zhao Y, Zhou S, Heng CK. Celecoxib Inhibits Serum Amyloid A-Induced Matrix Metalloproteinase-10 Expression in Human Endothe-lial Cells. J Vasc Res. 2008;46:64-72.